Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
暂无分享，去创建一个
Catherine C. Smith | E. A. Lasater | N. Shah | Kimberly C. Lin | L. Damon | Xiaotian Zhu | Whitney K. Stewart | S. Salerno
暂无分享，去创建一个
Catherine C. Smith | E. A. Lasater | N. Shah | Kimberly C. Lin | L. Damon | Xiaotian Zhu | Whitney K. Stewart | S. Salerno